Dr. Subil C. Go, MD

Dr. Go practices at DaVita Marysville Dialysis Center in Marysville, California.

Dr. Go's NPI, 1104043660, was assigned on April 19, 2007. Dr. Go graduated from University of the Philippines College of Medicine in 1999. Dr. Go holds California license A102159.

Dr. Go's primary practice is DaVita Marysville Dialysis Center, at 1015 8th Street, Marysville, CA 95901 in Yuba County. The practice phone is (310) 792-2603.

Dr. Go's primary practice is DaVita Marysville Dialysis Center in Marysville, California. Dr. Go is also affiliated with Adventist Health and Rideout. The medical group on file is North Valley Nephrology. Dmand AI also links Dr. Go to 4 more hospitals, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Go practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Go's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Go is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Go's licenses on file in 3 states: California, Rhode Island and Ohio.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and parathyroid gland disorder among the conditions Dr. Go treats.

CMS data shows 3,619 Medicare services from Dr. Go across 14 procedure codes in 2024, for 734 Medicare patients. Medicare paid $304,174 for them.

CMS counts 734 Medicare patients who saw Dr. Go in 2024. The largest group is 65 to 74, with 264 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 45% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Go's median patient age at 69, with 45% women.

In 2024, Dr. Go wrote 2,716 Medicare Part D claims for 347 patients. 76% of them were for generic drugs. CMS names the drug for 2,347 of them, across 55 drugs with 11 or more claims each, at $480,104 in total drug cost. In 2023, CMS named 2,341 claims across 58 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Go for performance year 2024, reported as part of a group. Dr. Go accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Go. Dr. Go's most frequent co-authors are Andrew Bostom, MD, Ritche C. Chiu, MD and Lance D. Dworkin, MD.

CMS Open Payments shows 7 general payments to Dr. Go from 5 drug and device companies from 2016 to 2024. Education make up the largest share, 52% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $96.

Dr. Go graduated from University of the Philippines College of Medicine in 1999.

Dr. Go is in network with 10 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.